Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-06-13-Speech-2-163"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20060613.24.2-163"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, Commissioner, ladies and gentlemen, I should like to begin by congratulating Mr Adamou on his report. Many Members have supported the idea of a strategic stockpile of antivirals, and I am delighted that the Committee on the Environment, Public Health and Food Safety should have accepted my proposal to implement a compulsory licensing system that should enable us to produce these antivirals more quickly and in far greater numbers so that at least 25% to 30% of the population is covered in each Member State.
The stockpile of antivirals is not enough, however. It is crucial that we increase the rate at which the vaccines are produced, because this will obviously be a deciding factor when it comes to limiting the pandemic. I regret that, from this perspective, the Union has not agreed to finance – or, at any rate, my fellow Members have not accepted its financing – a strategic public-private partnership on the subject of speeding up the production of vaccines against avian influenza.
My second point relates to antibiotics, which are in danger of running out once the influenza takes hold, because a whole series of complications will occur for which large stocks of antibiotics may prove necessary, mortality being due not only to the influenza, but also to the associated complications.
Thirdly, the danger of shortages: if we had to shift to producing extremely large amounts of antivirals in the European Union, the raw materials needed to make the antivirals and the masks could start to run out if the provision of supplies is not guaranteed and diversified.
Finally, since avian influenza is merely the first warning sign that major pandemics and epidemics, and particularly viral diseases, are developing on the planet, at a faster rate because of trade, it is altogether crucial that the Union takes the lead when it comes to producing new generation vaccines. My fellow Member, Mr Bowis, just spoke about this. The fact is, the very nature of our vaccines makes it difficult to produce them if we do not have any new strategies available to us. Finally, the WHO needs increased powers of surveillance and control because, from now on, we must be united. The surveillance and control network must be efficient and must operate on a worldwide scale."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples